Arama

EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

PDF

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 8 results

Ranking

Release Date Sort Sort Article Type

Decision for surgery in the management of a rare condition, childhood gallbladder polyps, and the role of ultrasonography

Gülşah BAYRAM KABAÇAM, Fatih AKBIYIK, Ziya LİVANELİOĞLU, H. Tuğrul TİRYAKİ, Esra KARAKUŞ, Gökhan KABAÇAM

(Turk J Gastroenterol 2013; 24: 556-560) DOI: 10.4318/tjg.2013.0848

Abstract Full Text ( PDF) Related Articles

How long should we treat patients with azathioprine/ 6-mercaptopurine before deciding that it is refractory to immunomodulatory treatment?

Gökhan KABAÇAM, Murat TÖRÜNER

(Turk J Gastroenterol 2012; 23: 13-16) DOI: 10.4318/tjg.2012.0617

Abstract Full Text ( PDF) Related Articles

Can azathioprine/6-mercaptopurine treatment be withdrawn in patients with response in ulcerative colitis: What is the most appropriate time for this?

Gökhan KABAÇAM, Murat TÖRÜNER

(Turk J Gastroenterol 2012; 23: 17-20) DOI: 10.4318/tjg.2012.0618

Abstract Full Text ( PDF) Related Articles

Decision for surgery in the management of a rare condition, childhood gallbladder polyps, and the role of ultrasonography

How long should we treat patients with azathioprine/ 6-mercaptopurine before deciding that it is refractory to immunomodulatory treatment?

Can azathioprine/6-mercaptopurine treatment be withdrawn in patients with response in ulcerative colitis: What is the most appropriate time for this?

Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis

When and how frequently DEXA should be performed for the diagnosis and follow-up of osteoporosis in Crohn’s disease?

What is the importance of anti-TNF agents in the treatment of luminal (inflammatory type) Crohn's disease?

Serum connective tissue markers as predictors of advanced fibrosis in patients with chronic hepatitis B and D

The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists